Lung cancer is the leading cause of cancer-related death in the U.S., but recent guidelines, if followed, can make it possible for smokers to avoid becoming part of that statistic.

Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

AI Lung Cancer Screening: A groundbreaking AI-driven screening initiative in Goa detects lung cancer in early stages, flagging over 500 high-risk patients and uncovering 7 previously undiagnosed ...

The researchers identified 1706 lung cancer cases over a mean follow-up of 12.2 years, including 1473 cases of NSCLC and 233 cases of SCLC.

The technology addresses a critical gap in lung cancer care as patients traditionally have to wait weeks or even months between diagnosis and surgery.

A University of York spin out which aims to revolutionise lung cancer diagnosis has reported further commercial progress in the US.

“Improved compliance with lung cancer screening guidelines may lead to earlier detection and improve radiotherapy and surgical outcomes.

“Improved compliance with lung cancer screening guidelines may lead to earlier detection and improve radiotherapy and surgical outcomes.

From small cell lung cancer treatment progress to broader breakthroughs The new endowed chair will allow MacPherson to move faster on discoveries that could change how SCLC is treated.

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung cancer.